Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maxsam Advisors is a private life sciences advisory firm focused on strategic clinical and medical affairs consulting for biotechnology and pharmaceutical clients. Publicly available references identify Laura Bessen, M.D., as managing partner, and describe the firm as providing strategic and board-level advice across the biotech and pharma industries. The company appears to operate as a specialized consultancy rather than a therapeutic developer, with no disclosed proprietary drug pipeline, platform technology, or in-house development programs. Based on available evidence, its value proposition centers on senior-level expertise in clinical development, medical affairs, commercialization strategy, and corporate advisory support for emerging and established life sciences companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maxsam Advisors.